Literature DB >> 14586529

Perioperative penetration of metronidazole into muscle tissue: a microdialysis study.

Juri Karjagin1, Rein Pähkla, Joel Starkopf.   

Abstract

OBJECTIVE: To evaluate the concentration of metronidazole in muscle tissue using microdialysis and to compare it with plasma concentration and in vitro-defined MIC(90) (minimal inhibiting concentration) for the most frequent anaerobic bacteria isolated in our hospital.
MATERIALS AND METHODS: Six female patients scheduled for elective gynaecological surgery were included. Exclusion criteria were active inflammatory process and being overweight (BMI more than 30). Microdialysis catheters (CMA 60 catheters with 20 kDa cut-off membrane) were placed into the m. vastus lateralis. The microdialysis perfusion rate was 2 microl/min. To assess in vivo recovery of the drug, retrodialysis with a 5-mg/l solution of metronidazole was performed. Microdialysis and blood samples were collected simultaneously 10 h after metronidazole administration. MIC(90) data were obtained from the database of the microbiology laboratory of the local hospital.
RESULTS: Data from five patients were included in analysis. The metronidazole concentration in blood achieved a value of 16.5+/-4.6 mg/l at 30 min (first available data), while in muscle a maximum level of 7.8+/-1.5 mg/l was achieved at 114 min. The mean MIC(90) for the Bacteroides fragilis group was 0.25+/-0.26 mg/l. Data from mean plasma concentrations were fitted into the two-compartmental model and time over MIC(90) and time over four times MIC(90) were calculated, which were 52.1+/-13.5 h and 33.2+/-8.7 h, respectively. The C(max)/MIC(90) ratio was 65.8+/-18.5 for plasma and 31.1+/-6.2 for muscle.
CONCLUSION: The present data demonstrate that metronidazole penetrates well into muscle tissue. Muscle tissue concentrations reach values far greater than MIC(90) for the Bacteroides fragilis group and persist at such high levels for at least 10 h.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14586529     DOI: 10.1007/s00228-003-0685-0

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  16 in total

1.  Target site concentrations after continuous infusion and bolus injection of cefpirome to healthy volunteers.

Authors:  U Hollenstein; M Brunner; B X Mayer; S Delacher; B Erovic; H G Eichler; M Müller
Journal:  Clin Pharmacol Ther       Date:  2000-03       Impact factor: 6.875

2.  Penetration of ciprofloxacin into the interstitial space of inflamed foot lesions in non-insulin-dependent diabetes mellitus patients.

Authors:  M Müller; M Brunner; U Hollenstein; C Joukhadar; R Schmid; E Minar; H Ehringer; H G Eichler
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

3.  Microvascular changes during anesthesia: sevoflurane compared with propofol.

Authors:  D Bruegger; A Bauer; U Finsterer; P Bernasconi; U Kreimeier; F Christ
Journal:  Acta Anaesthesiol Scand       Date:  2002-05       Impact factor: 2.105

4.  The pharmacokinetics of metronidazole and its metabolites in critically ill patients.

Authors:  K I Plaisance; R Quintiliani; C H Nightingale
Journal:  J Antimicrob Chemother       Date:  1988-02       Impact factor: 5.790

5.  Impaired target site penetration of beta-lactams may account for therapeutic failure in patients with septic shock.

Authors:  C Joukhadar; M Frossard; B X Mayer; M Brunner; N Klein; P Siostrzonek; H G Eichler; M Müller
Journal:  Crit Care Med       Date:  2001-02       Impact factor: 7.598

6.  Serum and tissue pharmacokinetics of intravenous metronidazole in surgical patients.

Authors:  P A Kling; L G Burman
Journal:  Acta Chir Scand       Date:  1989 Jun-Jul

Review 7.  Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials.

Authors:  K C Lamp; C D Freeman; N E Klutman; M K Lacy
Journal:  Clin Pharmacokinet       Date:  1999-05       Impact factor: 6.447

8.  Surgery and intensive care procedures affect the target site distribution of piperacillin.

Authors:  M Brunner; T Pernerstorfer; B X Mayer; H G Eichler; M Müller
Journal:  Crit Care Med       Date:  2000-06       Impact factor: 7.598

9.  Pharmacokinetics of metronidazole in severely malnourished and nutritionally rehabilitated children.

Authors:  I Lares-Asseff; J Cravioto; P Santiago; B Pérez-Ortíz
Journal:  Clin Pharmacol Ther       Date:  1992-01       Impact factor: 6.875

10.  Is antibiotic penetration compromised in the ischaemic tissues of patients undergoing amputation?

Authors:  M J Kerin; D Greenstein; E M Chisholm; S J Sheehan; R C Kester
Journal:  Ann R Coll Surg Engl       Date:  1992-07       Impact factor: 1.891

View more
  3 in total

Review 1.  Importance of relating efficacy measures to unbound drug concentrations for anti-infective agents.

Authors:  Daniel Gonzalez; Stephan Schmidt; Hartmut Derendorf
Journal:  Clin Microbiol Rev       Date:  2013-04       Impact factor: 26.132

Review 2.  A comprehensive review on the pharmacokinetics of antibiotics in interstitial fluid spaces in humans: implications on dosing and clinical pharmacokinetic monitoring.

Authors:  Tony K L Kiang; Urs O Häfeli; Mary H H Ensom
Journal:  Clin Pharmacokinet       Date:  2014-08       Impact factor: 6.447

Review 3.  Systemic and Target-Site Pharmacokinetics of Antiparasitic Agents.

Authors:  Valentin Al Jalali; Markus Zeitlinger
Journal:  Clin Pharmacokinet       Date:  2020-07       Impact factor: 6.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.